• EU e-Privacy Directive

    This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.

    View Privacy Policy

  • Italian - Italy
  • English (United Kingdom)
Home > News > ACTEA™ ORAL news February 2015
27 February 2015

ACTEA™ ORAL news February 2015

Candioli Farmaceutici presents the new frontier of stomatology: Actea™ Oral

Actea™ Oral is a highly adhesive stomatological protective gel indicated as an aid in the treatment of periodontal ailments in dogs and cats (e.g. gingivitis, stomatitis, periodontitis). It counters plaque formation and quickly reduces halitosis. Thanks to its protective action, Actea™ Oral quickly restores the physiological conditions of the oral cavity's mucous membranes, even after tartar removal and tooth extractions. Actea™ Oral contains LAS™, an exclusive formula, obtained thanks to innovative production processes (HTN™ TECHNOLOGY patent), result of three years of studies with the international scientific community, and concentrates in a macrocomplex natural antibacterial and anti-inflammatory properties. Thanks to LAS™, patented mix (patent pending) with natural molecules, Actea™ Oral can boast an effective control of inflammation, itching and bacterial and fungal overgrowth.

  • Innovative and exclusive formula, unique in veterinary
  • Quickly reduce halitosis
  • Effective in controlling the development of plaque
  • Good tolerability, also in cats, and easy to apply